Immunity after SARS-CoV-2 infections

被引：19
|
作者：
Jagannathan, Prasanna [1 ,2 ]
Wang, Taia T. [1 ,2 ,3 ]
机构：
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
来源：
NATURE IMMUNOLOGY | 2021年 / 22卷 / 05期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/s41590-021-00923-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
T cell responses probably play important roles in the control of SARS-CoV-2 infection, but they have been relatively understudied. Data now suggest that the majority of infected individuals develop robust and long-lasting T cell immunity, which has implications for the durability of immunity and future vaccine approaches.
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [31] Toward superhuman SARS-CoV-2 immunity?
    Burton, Dennis R.
    Topol, Eric J.
    NATURE MEDICINE, 2021, 27 (01) : 5 - 6
  • [32] Immunity to SARS-CoV-2: Lessons Learned
    Fergie, Jaime
    Srivastava, Amit
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] SARS-CoV-2 immunity in animal models
    Zhao Chen
    Yaochang Yuan
    Qingtao Hu
    Airu Zhu
    Fenghua Chen
    Shu Li
    Xin Guan
    Chao Lv
    Tian Tang
    Yiyun He
    Jinling Cheng
    Jie Zheng
    Xiaoyu Hu
    Jingxian Zhao
    Jincun Zhao
    Jing Sun
    Cellular & Molecular Immunology, 2024, 21 : 119 - 133
  • [34] Immunity to SARS-CoV-2 variants of concern
    Altmann, Daniel M.
    Boyton, Rosemary J.
    Beale, Rupert
    SCIENCE, 2021, 371 (6534) : 1103 - 1104
  • [35] T cell immunity to SARS-CoV-2
    Niessl, Julia
    Sekine, Takuya
    Buggert, Marcus
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [36] Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
    Uschner, Diane
    Bott, Matthew
    Lagarde, William H.
    Keating, Joseph
    Tapp, Hazel
    Berry, Andrea A.
    Seals, Austin L.
    Munawar, Iqra
    Schieffelin, John
    Yukich, Joshua
    Santacatterina, Michele
    Gunaratne, Mihili
    Fette, Lida M.
    Burke, Brian
    Strylewicz, Greg
    Edelstein, Sharon L.
    Ahmed, Amina
    Miller, Kristen
    Sanders, John W.
    Herrington, David
    Weintraub, William S.
    Runyon, Michael S.
    VACCINES, 2022, 10 (11)
  • [37] Breakthrough SARS-CoV-2 infections after vaccination: a critical review
    Afshar, Zeinab Mohseni
    Barary, Mohammad
    Hosseinzadeh, Rezvan
    Alijanpour, Amirmasoud
    Hosseinzadeh, Dariush
    Ebrahimpour, Soheil
    Nazary, Kosar
    Sio, Terence T.
    Sullman, Mark J. M.
    Carson-Chahhoud, Kristin
    Babazadeh, Arefeh
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [38] SARS-CoV-2: from herd immunity to hybrid immunity
    David Goldblatt
    Nature Reviews Immunology, 2022, 22 : 333 - 334
  • [39] Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
    Alessio Cortellini
    Juan Aguilar-Company
    Ramon Salazar
    Mark Bower
    Ailsa Sita-Lumsden
    Andrea Plaja
    Alvin J. X. Lee
    Alexia Bertuzzi
    Carlo Tondini
    Nikolaos Diamantis
    Clara Martinez-Vila
    Aleix Prat
    Eleanor Apthorp
    Alessandra Gennari
    David J. Pinato
    British Journal of Cancer, 2022, 127 : 1787 - 1792
  • [40] Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
    Cortellini, Alessio
    Aguilar-Company, Juan
    Salazar, Ramon
    Bower, Mark
    Sita-Lumsden, Ailsa
    Plaja, Andrea
    Lee, Alvin J. X.
    Bertuzzi, Alexia
    Tondini, Carlo
    Diamantis, Nikolaos
    Martinez-Vila, Clara
    Prat, Aleix
    Apthorp, Eleanor
    Gennari, Alessandra
    Pinato, David J.
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1787 - 1792
12345